Aarti Pharmalabs Reports Strong Q2 Results and Appoints New CFO
Aarti Pharmalabs Ltd 路 Change in Management 路 29 Oct 2026, 2:36 am
Aarti Pharmalabs Reports Strong Q2 Results and Appoints New CFO Aarti Pharmalabs posted a 45.9% YoY surge in Q2 consolidated revenue from operations to Rs 61,045.10 lakhs, with net profit rising 248.8% YoY to Rs 7,147.23 lakhs. For H1 ended 30th Sep'26, consolidated revenue grew 42.5% YoY to Rs 1,14,624.79 lakhs and net profit jumped 121.8% YoY to Rs 14,761.49 lakhs. The board accepted the resignation of CFO Piyush Lakhani, effective 30th Oct'26, and appointed Vibha Thakkar as CFO effective 31st Oct'26. Additionally, the company recognized an exceptional provision of Rs 204.00 lakhs regarding stamp duty disputes.
Original exchange filing (PDF)
More announcements from Aarti Pharmalabs Ltd
- Intimation of sad demise of Promoter and Chairman Emeritus of the Company 路 16 Nov 2026
- Q2 FY 27 Earnings Call Transcript 路 04 Nov 2026
- Audio Recording of Conference Call for Investor and Analysts 路 30 Oct 2026
- Q2 FY 2027 Investor Presentation 路 29 Oct 2026
- Please find enclosed 路 29 Oct 2026
- Please find enclosed 路 29 Oct 2026
- Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 29 Oct 2026
- Please find enclosed 路 29 Oct 2026
